Market Access Views & Analysis

Views & Analysis

Janssen’s Saskia De Haes, VP EMEA Regulatory Affairs, looks at how the pandemic response has shaped tomorrow’s regulatory landscape.

Views & Analysis

Leela Barham takes stock of past NICE decisions for combinations to explore the scale of the reimbursement challenge for combination therapies.

Views & Analysis

How could simplifying the administration of clinical trials help cancer diagnosis, care, and treatment levels to exceed pre-pandemic levels?

Views & Analysis

The National Institute for Health and Care Excellence (NICE) is quite far along a NICE-led process to

Digital

As demonstrated throughout COVID, digital health is no longer experimental.

Views & Analysis

The ABPI’s chief executive Dr Richard Torbett outlines a new ‘vision’ and